Keyphrases
Maori
100%
Androgen Deprivation Therapy
100%
Prostate Cancer Survivors
100%
Life Effects
100%
Genetic Stratification
100%
Therapy-related
100%
Related Quality of Life
100%
AKR1C3
60%
Quality of Life
40%
Single nucleotide Polymorphism
20%
Hormone Treatment
20%
Auckland
20%
Antiandrogen
20%
Androgens
20%
New Zealand
13%
Monotherapy
13%
Treatment-related Effects
13%
Urology
13%
Prostate Cancer Screening
6%
Informed Consent
6%
Confounding Variables
6%
Alcohol Consumption
6%
Clinical Diagnosis
6%
Quality of Life Assessment
6%
Palliation
6%
Survival Benefit
6%
Gleason Score
6%
Symptom Score
6%
Quality of Life Questionnaire
6%
Patient Well-being
6%
Cancer Treatment
6%
Prostate Radiotherapy
6%
Treatment Type
6%
Prostate-specific Antigen Level
6%
Decision Support
6%
EORTC QLQ-C30
6%
Advanced Prostate Cancer
6%
Allele Frequency
6%
Therapy Options
6%
Generalized Linear Model
6%
Duration of Therapy
6%
Treatment-related Symptoms
6%
European Organizations
6%
Testosterone
6%
Polymorphism
6%
District Health Boards
6%
Testicle
6%
Patient Cohort
6%
New Zealand Māori
6%
Insomnia
6%
GC Genotype
6%
Luteinizing Hormone
6%
Single nucleotide Polymorphism (SNP) Genotyping
6%
Androgen Production
6%
Androgen Receptor
6%
Downstream Products
6%
Ethnic Groups
6%
Androstenedione
6%
Asian Men
6%
MassARRAY
6%
Age at Diagnosis
6%
Waikato
6%
East Asia
6%
Adrenal Gland
6%
Late Presentation
6%
Therapy Groups
6%
TaqMan
6%
EORTC QLQ-PR25
6%
Genotype Data
6%
Anti-androgen Therapy
6%
Adrenal Androgens
6%
Sequenom
6%
Applied Biosystems
6%
Quality of Life Survey
6%
Blockage
6%
Medicine and Dentistry
Prostate Cancer
100%
Quality of Life
100%
Androgen Deprivation Therapy
100%
Aldo Keto Reductase
60%
Single Nucleotide Polymorphism
26%
Antiandrogen
26%
Androgen
20%
Allele
20%
Hormone Therapy
20%
Monotherapy
13%
Urology
13%
Diseases
6%
Primary Outcome
6%
Decision Making
6%
Prostate Specific Antigen
6%
Side Effect
6%
Prospective Study
6%
Cohort Analysis
6%
Symptomatic Treatment
6%
Malignant Neoplasm
6%
Gleason Score
6%
Treatment Duration
6%
Alcohol Consumption
6%
Cancer Therapy
6%
Written Consent
6%
Cancer Treatment
6%
Gene Frequency
6%
Testes
6%
Ethnic Group
6%
Gonadorelin Agonist
6%
Androstenedione
6%
Group Therapy
6%
Mecasermin Rinfabate
6%
Adrenal Gland
6%
Androgen Therapy
6%
Androgen Receptor
6%
Androgen Synthesis
6%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Aldo-Keto Reductase
100%
Single-Nucleotide Polymorphism
44%
Genotyping
44%
Allele
33%
Decision Making
11%
Prospective Study
11%
Cohort Study
11%
Enzyme
11%
Gene Frequency
11%
Gleason Score
11%
Gonadotropin-Releasing Hormone
11%
Agonist
11%
Prostate-Specific Antigen
11%
Androgen Receptor
11%
Androgen Synthesis
11%
Agricultural and Biological Sciences
Quality of Life
100%
Malignant Neoplasm
100%
Androgen
100%
Oxidoreductase
37%
Single Nucleotide Polymorphism
16%
Genotyping
16%
Allele
12%
Decision Making
4%
Receptor
4%
Polymorphism
4%
Prostate-Specific Antigen
4%
Gonadotropin-Releasing Hormone Agonist
4%
Androstenedione
4%
Adrenal Gland
4%
Testes
4%
Gene Frequency
4%
Linear Models
4%
Neuroscience
Quality of Life
100%
Androgen
100%
Aldo Keto Reductase
47%
Prostate
26%
Single-Nucleotide Polymorphism
21%
Antiandrogen
21%
Hormone Therapy
15%
Decision Making
5%
Side Effect
5%
Allele Frequency
5%
Generalized Linear Model
5%
Mecasermin Rinfabate
5%
Adrenal Gland
5%
Group Therapy
5%
Androgen Receptor
5%
Gonadotropin-Releasing Hormone Agonist
5%
Prostate Specific Antigen
5%
Androstenedione
5%